Literature DB >> 3486685

Etiologic aspects of cold agglutinin disease: evidence for cytogenetically defined clones of lymphoid cells and the demonstration that an anti-Pr cold autoantibody is derived from a chromosomally aberrant B cell clone.

L E Silberstein, G A Robertson, A C Harris, L Moreau, E Besa, P C Nowell.   

Abstract

This study investigated the clonal nature of cold agglutinin disease in a series of nine patients, which included the benign or idiopathic form as well as cases with an underlying lymphoma. Surface marker phenotyping and karyotypic analysis were performed on peripheral blood lymphocytes. An increased proportion of B cells was found in four cases and in three of these patients a monoclonal B cell population was identified with a mu, kappa phenotype. In the same three cases, as well as an additional patient, an aberrant karyotype was demonstrated. The cytogenetic abnormality present in all four cases included trisomy 3; two patients also had a trisomy 12. One of these four patients had a well-differentiated lymphoma and underwent a splenectomy. Splenic lymphocytes were transformed with Epstein-Barr virus and cultured en masse. Eight clones were established producing the same cold agglutinin with identical specificity as that present in the patient's plasma. Five of these clones were studied cytogenetically, and all had the same abnormal karyotype (51,XX,+3,+9,+12,+13,+18) found in peripheral blood and splenic lymphocytes. Thus, in this case, the cold reactive autoantibody was produced by the chromosomally abnormal, neoplastic clone of lymphocytes. Our findings support the view that cold agglutinin disease represents a spectrum of clonal disorders.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486685

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Spurious macrocytosis associated with non-Hodgkin's lymphoma: report of two cases.

Authors:  K Moridaira; H Murakami; T Kitahara; J Tamura; T Matsushima; M Sawamura; T Naruse; K Kubota; N Tsukamoto; S Sato
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

Review 2.  Natural and pathologic human autoimmune responses to carbohydrate antigens on red blood cells.

Authors:  L E Silberstein
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Successful response to alpha-interferon 2b in a refractory IgM autoagglutinin-mediated hemolytic anemia.

Authors:  T Fest; B de Wazières; B Lamy; M Maskani; D Vuitton; J L Dupond
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

4.  Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy.

Authors:  Hiroaki Tanaka; Shinichiro Hashimoto; Yasumasa Sugita; Shio Sakai; Yusuke Takeda; Daijiro Abe; Toshiyuki Takagi; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2012-08-11       Impact factor: 2.490

5.  Relationship of variable region genes expressed by a human B cell lymphoma secreting pathologic anti-Pr2 erythrocyte autoantibodies.

Authors:  L E Silberstein; S Litwin; C E Carmack
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

Review 6.  Autoimmune Hemolysis: A Journey through Time.

Authors:  John Freedman
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

7.  The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma.

Authors:  D F Friedman; E A Cho; J Goldman; C E Carmack; E C Besa; R R Hardy; L E Silberstein
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

Review 8.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.